BeStock  
Stocks › Biotechnology › LTGO

Latigo Biotherapeutics LTGO

US equityMarket cap rank #3223Biotechnology
$15.52 −$0.74 (-4.55%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $15.89 +2.38%
Open$16.22
Prev close$16.26
Day range$15.27 – $16.35
Volume241.5K
Market cap$1.03B
P/E (TTM)–
Dividend yield–

LTGO Stock News

Headlines matching Latigo Biotherapeutics or the LTGO ticker, most recent first.

  • Goldman Sachs Maintains Latigo Biotherapeutics(LTGO.US) With Buy Rating, Maintains Target Price $73Market news · 4 Sep 2026 · Direct mention
  • Guggenheim Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50Market news · 2 Sep 2026 · Direct mention
  • Jefferies Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $50Market news · 2 Sep 2026 · Direct mention
  • Analysts Offer Insights on NA Companies: Latigo Biotherapeutics, Inc. (LTGO), Golar LNG (GLNG) and Mobility Global Inc (MBGL)TipRanks · 2 Sep 2026 · Direct mention
  • Goldman Sachs Initiates Latigo Biotherapeutics(LTGO.US) With Buy Rating, Announces Target Price $73Market news · 1 Sep 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on LTGO.

Leave a comment

Scroll to Top